Replies to post #171870 on Amarin Corp Plc (AMRN)

[sts66]

In China, it was suggested in an analyst opinion, that the retail price might have to go to $1.00 per day to be viable.

I'm pretty sure when all-in costs are included selling at that price is a money loser - HDG has guesstimated either what a cap costs or what a 30 day supply costs, and IIRC it's > $1/cap. Note: this is not the cost of API and producing a cap, it's total cost to make and sell that cap.

[ChrisInSF]

Im with you. I think Vascepa is a $15+ billion annual drug (I think that's actually low).

I just think that unless a bidding war gets going, you're stuck below $50 until people wake up and realize how fast this drug is expanding share and saving lives.

IF we were to get a bidding war, I think it would be nuts. Crazy good.

But we got to get here first.

Here's to hoping that day is Monday